Rituxan 500 MG/50 ML vial 50ML
Ended Awarded
- Contract number
- SPE2DB25FAZHQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,932
Award facts
- Contract value 100% obligated
- $11,931.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On June 2, 2025, the Defense Logistics Agency awarded a delivery order valued at $11,931.76 to DMS Pharmaceutical Group Inc. for the supply of Rituxan 500 mg/50 ml vials. This firm fixed-price delivery order, with an ultimate completion date of June 24, 2025, represents a continuation of pharmaceutical supply services under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract was awarded without a set-aside designation, and the product will be delivered to Park Ridge, Illinois, where the vendor is based.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, operates as a key supplier within the federal pharmaceutical supply chain for Department of Defense healthcare facilities. The company holds a significant single-award IDC with the DLA valued at $499,999,999 through November 2026, which authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. This delivery order for Rituxan, a biologic used in oncology and rheumatology treatments, exemplifies the company's role in supporting military health system requirements across the nation.
Quick answers
Who was awarded contract SPE2DB25FAZHQ?
SPE2DB25FAZHQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FAZHQ worth?
The government has obligated $11,932 on SPE2DB25FAZHQ.
Is contract SPE2DB25FAZHQ an order under another contract?
Yes. SPE2DB25FAZHQ is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZHQ competed?
The extent of competition for SPE2DB25FAZHQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award